APO RESEARCH · REPORT
Tuberculosis (TB) Detection
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Product & engineering
Understand the product.
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.
Selected research
Industry Growth & Trends
Global Tuberculosis (TB) Detection Industry Growth and Trends Forecast to 2032
Market perspective
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.
According to APO Research, the global Tuberculosis (TB) Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Tuberculosis (TB) Detection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tuberculosis (TB) Detection market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tuberculosis (TB) Detection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tuberculosis (TB) Detection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tuberculosis (TB) Detection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tuberculosis (TB) Detection Market by Company
Danaher
Roche
Thermal Fisher
Abbott
Oxford Immunotec International
Qiagen
Hologic
Hain Lifescience
Epistem
Creative Diagnostics
Tuberculosis (TB) Detection Segment by Type
Bacterial Culture Test
Tuberculin Test
Rapid Molecular Diagnosis
Other
Tuberculosis (TB) Detection Segment by Application
Hospital
Clinic
Research Institution
Other
Tuberculosis (TB) Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tuberculosis (TB) Detection companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Bacterial Culture Test
- Tuberculin Test
- Rapid Molecular Diagnosis
- Other
Applications
- Hospital
- Clinic
- Research Institution
- Other
Companies covered
- Danaher
- Roche
- Thermal Fisher
- Abbott
- Oxford Immunotec International
- Qiagen
- Hologic
- Hain Lifescience
- Epistem
- Creative Diagnostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tuberculosis (TB) Detection Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tuberculosis (TB) Detection Market Size by Region (2021-2032)
- 1.4.1 Global Tuberculosis (TB) Detection Market Size by Region (2021-2026)
- 1.4.2 Global Tuberculosis (TB) Detection Market Size by Region (2027-2032)
- 1.5 Key Regions Tuberculosis (TB) Detection Market Size (2021-2032)
- 1.5.1 North America Tuberculosis (TB) Detection Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tuberculosis (TB) Detection Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tuberculosis (TB) Detection Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tuberculosis (TB) Detection Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tuberculosis (TB) Detection Market Size Growth Rate (2021-2032)
2 Tuberculosis (TB) Detection Market by Type
- 2.1 Type Introduction
- 2.1.1 Bacterial Culture Test
- 2.1.2 Tuberculin Test
- 2.1.3 Rapid Molecular Diagnosis
- 2.1.4 Other
- 2.2 Global Tuberculosis (TB) Detection Market Size by Type
- 2.2.1 Global Tuberculosis (TB) Detection Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tuberculosis (TB) Detection Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tuberculosis (TB) Detection Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tuberculosis (TB) Detection Market Size by Regions
- 2.3.1 North America Tuberculosis (TB) Detection Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tuberculosis (TB) Detection Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tuberculosis (TB) Detection Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tuberculosis (TB) Detection Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tuberculosis (TB) Detection Market Size Breakdown by Type (2021-2026)
3 Tuberculosis (TB) Detection Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Research Institution
- 3.1.4 Other
- 3.2 Global Tuberculosis (TB) Detection Market Size by Application
- 3.2.1 Global Tuberculosis (TB) Detection Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tuberculosis (TB) Detection Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tuberculosis (TB) Detection Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tuberculosis (TB) Detection Market Size by Regions
- 3.3.1 North America Tuberculosis (TB) Detection Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tuberculosis (TB) Detection Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tuberculosis (TB) Detection Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tuberculosis (TB) Detection Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tuberculosis (TB) Detection Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tuberculosis (TB) Detection Industry Trends
- 4.2 Tuberculosis (TB) Detection Industry Drivers
- 4.3 Tuberculosis (TB) Detection Industry Opportunities and Challenges
- 4.4 Tuberculosis (TB) Detection Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tuberculosis (TB) Detection Revenue (2021-2026)
- 5.2 Global Tuberculosis (TB) Detection Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tuberculosis (TB) Detection Key Company Headquarters & Area Served
- 5.4 Global Tuberculosis (TB) Detection Company, Product Type & Application
- 5.5 Global Tuberculosis (TB) Detection Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tuberculosis (TB) Detection Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tuberculosis (TB) Detection Players Market Share by Revenue in 2025
- 5.6.3 2025 Tuberculosis (TB) Detection Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Danaher
- 6.1.1 Danaher Company Information
- 6.1.2 Danaher Business Overview
- 6.1.3 Danaher Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Danaher Tuberculosis (TB) Detection Product Portfolio
- 6.1.5 Danaher Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Tuberculosis (TB) Detection Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Thermal Fisher
- 6.3.1 Thermal Fisher Company Information
- 6.3.2 Thermal Fisher Business Overview
- 6.3.3 Thermal Fisher Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Thermal Fisher Tuberculosis (TB) Detection Product Portfolio
- 6.3.5 Thermal Fisher Recent Developments
- 6.4 Abbott
- 6.4.1 Abbott Company Information
- 6.4.2 Abbott Business Overview
- 6.4.3 Abbott Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Abbott Tuberculosis (TB) Detection Product Portfolio
- 6.4.5 Abbott Recent Developments
- 6.5 Oxford Immunotec International
- 6.5.1 Oxford Immunotec International Company Information
- 6.5.2 Oxford Immunotec International Business Overview
- 6.5.3 Oxford Immunotec International Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Oxford Immunotec International Tuberculosis (TB) Detection Product Portfolio
- 6.5.5 Oxford Immunotec International Recent Developments
- 6.6 Qiagen
- 6.6.1 Qiagen Company Information
- 6.6.2 Qiagen Business Overview
- 6.6.3 Qiagen Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Qiagen Tuberculosis (TB) Detection Product Portfolio
- 6.6.5 Qiagen Recent Developments
- 6.7 Hologic
- 6.7.1 Hologic Company Information
- 6.7.2 Hologic Business Overview
- 6.7.3 Hologic Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Hologic Tuberculosis (TB) Detection Product Portfolio
- 6.7.5 Hologic Recent Developments
- 6.8 Hain Lifescience
- 6.8.1 Hain Lifescience Company Information
- 6.8.2 Hain Lifescience Business Overview
- 6.8.3 Hain Lifescience Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Hain Lifescience Tuberculosis (TB) Detection Product Portfolio
- 6.8.5 Hain Lifescience Recent Developments
- 6.9 Epistem
- 6.9.1 Epistem Company Information
- 6.9.2 Epistem Business Overview
- 6.9.3 Epistem Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Epistem Tuberculosis (TB) Detection Product Portfolio
- 6.9.5 Epistem Recent Developments
- 6.10 Creative Diagnostics
- 6.10.1 Creative Diagnostics Company Information
- 6.10.2 Creative Diagnostics Business Overview
- 6.10.3 Creative Diagnostics Tuberculosis (TB) Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Creative Diagnostics Tuberculosis (TB) Detection Product Portfolio
- 6.10.5 Creative Diagnostics Recent Developments
7 North America
- 7.1 North America Tuberculosis (TB) Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 7.3 North America Tuberculosis (TB) Detection Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tuberculosis (TB) Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 8.3 Europe Tuberculosis (TB) Detection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tuberculosis (TB) Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tuberculosis (TB) Detection Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tuberculosis (TB) Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 10.3 South America Tuberculosis (TB) Detection Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tuberculosis (TB) Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tuberculosis (TB) Detection Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst